Amgen Stock Climbs on Rising Earnings Guidance and Dividend Strength

Amgen's stock price surged on September 18, 2026, closing at $385.65 on Nasdaq, a gain of 1.55% from the previous session.

The biotech group's rising earnings guidance and dividend profile have attracted investors' attention.

As reported by Yahoo Finance, Amgen pays a quarterly dividend of $2.52 per share, which annualizes to $10.08 and implies a yield of about 2.6% at the current share price.

The company's management has raised its 2026 earnings per share guidance to a range of $22.30 to $23.50, signaling confidence that the business can cover and grow its dividend from operating performance rather than financial engineering.